Skip to main content
AAPA 2025 Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Invitation Only
Invitation Only
Ticketed - Complimentary
Ticketed - Complimentary
Ticketed - Additional Fee Required
Ticketed - Additional Fee Required
Capturing for On Demand
Capturing for On Demand
Pharmacology
Pharmacology
National Health Priorities
National Health Priorities
Potential State Requirement
Potential State Requirement
Project Innovation
Project Innovation
PA Administrative Competencies
PA Administrative Competencies

GAST-Gastroenterology

Satellite Symposium: On Your Mark, Get Set, Go! A GERD Grand Prix Challenge

Friday, May 16, 2025
6:30 PM – 7:45 PM  
Location: Colorado Convention Center, Mile High Ballroom 3

Please click here to register to for this session to attend this session.

This activity has been approved for 1.25 AAPA Category 1 CME credits.

Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders seen in primary care. Patients with GERD experience substantial burden, and symptoms frequently persist despite ongoing treatment. In this case-based symposium, compete against your colleagues as you engage in a virtual race and unlock critical information about GERD diagnosis and management. Learn from expert faculty who will discuss the latest clinical evidence on newly approved treatments with novel mechanisms of action that can treat both erosive and nonerosive GERD. Hear from a patient who will describe their journey and challenges living with GERD. So, start your engines and join us for this engaging case challenge!

This activity is supported by an independent educational grant from Phathom Pharmaceuticals.

This symposium is neither supported, sponsored, nor endorsed by AAPA.

Learning Objectives:

At the conclusion of this session, participants should be able to:
  • Have increased knowledge regarding the differences and similarities between erosive and non-erosive GERD
  • Have increased knowledge regarding the evidence for new acid-suppressive agents for GERD treatment
  • Recommend acid-suppressive therapies for patients with GERD
  • Incorporate new acid-suppressive treatments for GERD into routine practice